Literature DB >> 23912735

India's regulatory reforms on compensation for clinical trial injuries and deaths: urgent need for revisiting.

Jerome Amir Singh1.   

Abstract

Mesh:

Year:  2013        PMID: 23912735     DOI: 10.20529/IJME.2013.057

Source DB:  PubMed          Journal:  Indian J Med Ethics        ISSN: 0974-8466


× No keyword cloud information.
  5 in total

1.  The need for healthcare reforms: is no-fault liability the solution to medical malpractice?

Authors:  Shivkrit Rai; Vishwas H Devaiah
Journal:  Asian Bioeth Rev       Date:  2019-04-04

2.  A Case-Study of the Resources and Functioning of Two Research Ethics Committees in Western India.

Authors:  Tiffany Chenneville; Lynette Menezes; Jayendrakumar Kosambiya; Rajendra Baxi
Journal:  J Empir Res Hum Res Ethics       Date:  2016-07-31       Impact factor: 1.742

3.  Compensation for clinical trial-related injury and death in India: challenges and the way forward.

Authors:  Yogendra Kumar Gupta; Arun Kumar Pradhan; Aman Goyal; Prafull Mohan
Journal:  Drug Saf       Date:  2014-12       Impact factor: 5.606

4.  Need for revision: EC process, members' training, and compensation formula in the New Drugs and Clinical Trials Rules 2019.

Authors:  Ravindra Bhaskar Ghooi
Journal:  Perspect Clin Res       Date:  2022-06-30

5.  Disparate compensation policies for research related injury in an era of multinational trials: a case study of Brazil, Russia, India, China and South Africa.

Authors:  George Rugare Chingarande; Keymanthri Moodley
Journal:  BMC Med Ethics       Date:  2018-02-17       Impact factor: 2.652

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.